{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18074852", "DateCompleted": {"Year": "2008", "Month": "07", "Day": "24"}, "DateRevised": {"Year": "2007", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-4454", "JournalIssue": {"Volume": "30", "Issue": "8", "PubDate": {"Year": "2007", "Month": "Aug"}}, "Title": "Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials", "ISOAbbreviation": "Zhong Yao Cai"}, "ArticleTitle": "[The empirical study of Maxingganshi decoction and its compatibility in acute lung injury rats].", "Pagination": {"StartPage": "984", "EndPage": "989", "MedlinePgn": "984-9"}, "Abstract": {"AbstractText": ["To explore the pharmacodyniamic action and the mechanism of action of the Maxingganshi decoction in acute lung injury rats in order to supply the pharmacology evidence to cure the SIRS-ALI of Maxingganshi decoction.", "The study designed by orthogonal design. The SIRS-ALI model were Conseructed by the LPS intravenous injection and the effects of Maxingganshi decoction and it's different compatibilities to the SIRS-ALI model were observed. The experiments results were analvsised in order to reveal the compatibility rules of the Maxingganshi decocotion.", "Maxingganshi decocotion and its different compatibilities had good effects of prevention and cure the SIRS-ALI. The mechanism maybe concerned with the Maxingganshi decocotion can decrease the TNF-alpha and increase the IL-10. The experiments results also indicated that the action of the full formula was the best. The principal drug was the most important in the formula.", "Maxingganshitang has a good effect in anti the ALI; the results indicat that the principal drug is the predominant therapeutic action in the formula ministerial drug. Adjuvant drug and messenger drug can strengthen pharmacodynamic action."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Health Care Hospital for Women and Children, Guangzhou 510010, China."}], "Identifier": [], "LastName": "Wang", "ForeName": "Wei-guang", "Initials": "WG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shi", "ForeName": "Xu-guang", "Initials": "XG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhai", "ForeName": "Li-xiang", "Initials": "LX"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Pei-jian", "Initials": "PJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Peng", "ForeName": "Xiu-feng", "Initials": "XF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xu", "ForeName": "Yu-ying", "Initials": "YY"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhong Yao Cai", "NlmUniqueID": "9426370", "ISSNLinking": "1001-4454"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "maxingganshi"}, {"RegistryNumber": "130068-27-8", "NameOfSubstance": "Interleukin-10"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acute Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Capillary Permeability"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["blood"], "DescriptorName": "Interleukin-10"}, {"QualifierName": ["blood", "drug therapy", "pathology"], "DescriptorName": "Lung Diseases"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["blood", "drug therapy", "pathology"], "DescriptorName": "Pulmonary Edema"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["blood", "drug therapy", "pathology"], "DescriptorName": "Systemic Inflammatory Response Syndrome"}, {"QualifierName": ["blood"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "12", "Day": "14", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "7", "Day": "25", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "12", "Day": "14", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18074852"]}}], "PubmedBookArticle": []}